All information on this website is intended strictly for educational and research purposes only.
The content on OpenPep — including peptide profiles, clinical trial summaries, dosing information, and reconstitution calculators — must not be used for:
OpenPep aggregates publicly available clinical trial data and research. We do not sell, distribute, or recommend any substances. All AI-generated summaries are interpretations of published research and may contain errors.
Thymosin Alpha-1
For educational and research purposes only. Not medical advice.
Thymosin Alpha-1 is the most clinically validated immune peptide, approved in 37 countries. Used as adjunct therapy for hepatitis B/C, cancer, and immune deficiency. Over 80 clinical trials support its efficacy and safety profile.
Best Time
Morning
Method
subcutaneous
Frequency
2-3x per week
Half-life
~2 hours
Cycle Length
6-12 months or ongoing
Storage
Refrigerate at 2-8°C.
Published Dosing Ranges
Create an account to access peptide research data.
Contraindications
Create an account to access peptide research data.
Both are thymic peptides supporting immune function. Thymosin Alpha-1 is a defined single peptide while Thymalin is a thymic extract. Overlapping mechanism — generally choose one for immune rejuvenation.
communityBPC-157's tissue repair combined with Thymosin Alpha-1's immune modulation. Theoretical synergy for healing in immunocompromised contexts.
theoreticalThymosin Alpha-1 modulates adaptive immunity (T-cell maturation, dendritic cell activation) while LL-37 provides innate antimicrobial defense. Complementary immune system support across both arms.
theoreticalJournal of viral hepatitis 19 Suppl 1 :52-9 · 2012-01-01
Expert opinion on biological therapy 18 (sup1) :61-69 · 2018-07-01
Scientific reports 9 (1) :10310 · 2019-07-16
Journal of preventive medicine and hygiene 52 (3) :111-5 · 2011-09-01
Journal of gastroenterology and hepatology 23 (5) :729-35 · 2008-05-01
Mechanism of Action
Enhances T-cell maturation and function, activates dendritic cells, promotes Th1 immune response, and modulates toll-like receptor signaling. Restores immune balance.
Reported by the community. These may not be supported by clinical evidence and are not medical recommendations.